Company research
SBC Medical Group Holdings Inc
CIK 1930313Updated Sep 26, 2026
Name history
Pono Capital Two, Inc. · through Aug 29, 2024
SBC price & chart
Loading TradingView…
NASDAQ:SBC on TradingView ↗About the company
SBC Medical is a Medical Services Organization providing management support across a wide range of healthcare fields, including advanced aesthetic healthcare, dermatology, orthopedics, fertility treatment, gynecology, dentistry, alopecia treatment (AGA), and ophthalmology. The Company manages a diverse portfolio of clinic brands and is actively expanding its global presence, particularly in the United States and Asia, through both direct operations and medical tourism initiatives. In September 2024, the Company was listed on Nasdaq, and in June 2025, it was selected for inclusion in the Russell 3000® Index, a broad benchmark of the U.S. equity market. Guided by its Group Purpose “Contributing to the well-being of people around the world through medical innovation,” SBC Medical continues to provide safe, trusted, and high-quality medical services while further strengthening its international reputation for quality and trust in medical care.
In the news
No coverage from other publishers is available.
Recent filings
10-Q filing
Results of Operations and Financial Condition · Regulation FD Disclosure
Items 2.02, 7.01, 9.01
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · Material Modification to Rights of Security Holders · Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Submission of Matters to a Vote of Security Holders
Items 3.01, 3.03, 5.03, 5.07, 9.01
ARS filing
DEFA14A filing
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 380,447,946Source | 266,083,154Source | 21,245,336Source | 119,942,205Source |
| Property, Plant and Equipment, NetUSD | 7,539,392Source | 8,771,902Source | — | — |
| GoodwillUSD | 15,432,061Source | 4,613,784Source | — | — |
| Intangible Assets, Net (Excluding Goodwill)USD | 47,742,888Source | 1,590,052Source | — | — |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 163,773,838Source | 125,044,092Source | — | 485,564Source |
| Inventory, NetUSD | 2,792,617Source | 1,494,891Source | — | — |
| Assets, CurrentUSD | 231,224,115Source | 184,451,020Source | 394,543Source | 722,189Source |
| Prepaid Expense and Other Assets, CurrentUSD | 11,724,852Source | 11,276,802Source | — | — |
| Operating Lease, Right-of-Use AssetUSD | 8,366,569Source | 5,267,056Source | — | — |
| Other Assets, NoncurrentUSD | 7,263,692Source | 15,553,453Source | — | — |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 117,143,240Source | 71,060,996Source | 6,634,044Source | 4,591,012Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | — | — | — |
| Common Stock, Value, IssuedUSD | 10,388Source | 10,302Source | — | — |
| Additional Paid in CapitalUSD | 72,867,424Source | 62,513,923Source | — | — |
| Retained Earnings (Accumulated Deficit)USD | 240,448,620Source | 189,463,007Source | -5,995,269Source | -3,359,028Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -57,294,239Source | -54,178,075Source | — | — |
| Stockholders' Equity Attributable to ParentUSD | 248,282,196Source | 195,109,157Source | -5,994,912Source | -3,358,671Source |
| Liabilities and EquityUSD | 380,447,946Source | 266,083,154Source | 21,245,336Source | 119,942,205Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 61,121,003Source | 61,191,890Source | 2,609,044Source | 566,012Source |
| Operating Lease, Liability, CurrentUSD | 4,416,960Source | 4,341,522Source | — | — |
| Accounts Payable, CurrentUSD | — | — | 43,910Source | 79,440Source |
| Operating Lease, Liability, NoncurrentUSD | 4,136,257Source | 1,241,526Source | — | — |
| Other Liabilities, NoncurrentUSD | 1,660,183Source | 1,193,541Source | — | — |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 15,022,510Source | -86,999Source | — | — |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | — | — | 480,050Source | 76,420Source |
| Deferred Tax Liabilities, NetUSD | 16,374,832Source | 926,023Source | — | — |
| Long-term DebtUSD | 42,833,484Source | 6,599,506Source | — | — |
| Short-term InvestmentsUSD | 319,193Source | — | — | — |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Cash flows from operating activities: | |||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | 51,045,023Source | 46,689,892Source | — |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Depreciation, Depletion and AmortizationUSD | 2,684,300Source | 3,799,377Source | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 0Source | 13,022,692Source | — |
| Changes in operating assets and liabilities: | |||
| Increase (Decrease) in InventoriesUSD | 170,174Source | -1,124,805Source | — |
| Increase (Decrease) in Accounts PayableUSD | — | — | -35,530Source |
| Deferred Income Tax Expense (Benefit)USD | 5,326,982Source | -14,417,087Source | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 24,668,496Source | 20,582,933Source | -2,132,921Source |
| Cash flows from investing activities: | |||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -20,971,552Source | -10,102,410Source | 101,010,630Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 1,401,012Source | 2,564,643Source | — |
| Cash flows from financing activities: | |||
| Payments for Repurchase of Common StockUSD | 4,999,997Source | — | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 38,292,183Source | 22,965,400Source | -99,078,879Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 38,729,746Source | 22,021,160Source | -201,170Source |
| Supplemental disclosure of cash flow information: | |||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 160,583Source | 28,300Source | — |
| Income Taxes Paid, NetUSD | 37,190,188Source | 30,239,002Source | — |
| Additional Financial Items | |||
| Amortization of Intangible AssetsUSD | 573,438Source | 1,073,029Source | — |
| DepreciationUSD | 2,007,164Source | 2,726,348Source | — |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | 2,002,789Source | — | — |
| Gain (Loss) on Disposition of AssetsUSD | 3,145,622Source | -511,947Source | — |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | 2,750,628Source | 325,761Source | — |
| GoodwillUSD | 15,432,061Source | 4,613,784Source | — |
| Impairment of Intangible Assets (Excluding Goodwill)USD | 0Source | 15,058,965Source | — |
| Income Tax Expense (Benefit)USD | 31,020,607Source | 26,765,925Source | 528,809Source |
| InterestExpenseNonoperatingUSD | 160,583Source | 28,300Source | — |
| Investment Income, InterestUSD | 198,315Source | 19,943Source | — |
| Net Income (Loss) Attributable to ParentUSD | 50,985,613Source | 46,614,275Source | 339,767Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | 59,410Source | 75,617Source | — |
| Nonoperating Income (Expense)USD | 14,579,232Source | 3,152,107Source | — |
| Operating ExpensesUSD | 59,797,324Source | 85,746,797Source | 1,635,452Source |
| Operating Lease, Impairment LossUSD | 0Source | — | — |
| Unrealized Gain (Loss) on InvestmentsUSD | 247,514Source | — | — |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Total RevenueUSD | 173,607,489Source | 205,415,542Source | — |
| Cost of Goods and Services Sold | — | — | — |
| Selling, General and Administrative ExpenseUSD | 59,797,324Source | 57,665,140Source | — |
| Operating Income (Loss)USD | 67,486,398Source | 70,303,710Source | -1,772,831Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 82,065,630Source | 73,455,817Source | 868,576Source |
| Income Tax Expense (Benefit)USD | 31,020,607Source | 26,765,925Source | 528,809Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | 59,410Source | 75,617Source | — |
| Net Income (Loss) Attributable to ParentUSD | 50,985,613Source | 46,614,275Source | 339,767Source |
| Earnings Per Share, BasicUSD per share | 0.5Source | 0.48Source | — |
| Earnings Per Share, DilutedUSD per share | 0.5Source | 0.48Source | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 102,997,967Source | 96,561,041Source | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 102,997,967Source | 96,561,041Source | — |
| Interest Expense (non-operating)USD | 160,583Source | 28,300Source | — |
| Additional Financial Items | |||
| Amortization of Intangible AssetsUSD | 573,438Source | 1,073,029Source | — |
| Current Income Tax Expense (Benefit)USD | 25,693,625Source | 41,183,012Source | — |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | 2,002,789Source | — | — |
| Gross ProfitUSD | 127,283,722Source | 156,050,507Source | — |
| Interest and Other IncomeUSD | 1,212,626Source | 1,075,094Source | — |
| Interest ExpenseUSD | 148,238Source | 28,300Source | — |
| Investment Income, InterestUSD | 198,315Source | 19,943Source | — |
| Nonoperating Income (Expense)USD | 14,579,232Source | 3,152,107Source | — |
| Operating ExpensesUSD | 59,797,324Source | 85,746,797Source | 1,635,452Source |
Filing attachments
sbc-ex99_1.htm · 8-K · 2026-08-13
EX-99.1 2 sbc-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 SBC Medical Group Holdings Reports Second Quarter 2026 Financial Results Restructuring Complete, Growth Reaccelerates: Q2 Revenue Up 13%, Net Income Attributable to SBC Medical Up 335%, Adjusted EBITDA1 Up 32% Year-over-Year. AI-Enabled Service Enhancements Drive Successful Fee Increases, Positioning the Business for Accelerated Network Expansion - (BUSINESS WIRE) - IRVINE, Calif. -- SBC Medical Group Holdings Incorporated (Nasdaq: S…
Read attachment ↗sbc-ex99_1.htm · 8-K · 2026-05-14
EX-99.1 2 sbc-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 SBC Medical Group Holdings Announces First Quarter 2026 Financial Results IRVINE, Calif. --SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Medical Services Organization providing management support across a wide range of healthcare fields, today announced its financial results for the three months ended March 31, 2026. First Quarter 2026 Highlights • Total revenues were $43 million, represent…
Read attachment ↗ex99-1.htm · 8-K · 2026-03-27
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 SBC Medical Announces Fourth Quarter and Full Year 2025 Financial Results Q4 EPS more than doubles to $0.14 as profitability improves significantly year over year IRVINE, Calif. --SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced its financial results for the fourth quarter of fiscal…
Read attachment ↗